Centre Hospitalier Intercommunal de Créteil
Créteil, Creteil, 77500, France
NCT Number: NCT03235011
Evaluation of knowledge about contraception in sickle cell adolescents.
Looking for future studies?
Notify Me14 year–19 year
All sexes
Observational
Créteil, Creteil, 77500, France
Sickle cell teenagers receive regular hospital medical care.
Adolescence is the time when the pathophysiology of the disease is re-explained and when questions around puberty (possibly delayed), sexuality and contraception are discussed.
Sickle cell disease, like any chronic disease, can have repercussion on the development and behavior of young patients.
Knowledge and understanding of young patients with sickle cell disease around these issues may be insufficient.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at inclusion
questionnaire on general knowledge on contraception rated by 4 questions
Time frame: at inclusion
Time frame: at inclusion
Time frame: at inclusion
Time frame: at inclusion
Time frame: at inclusion
Time frame: at inclusion
Time frame: at inclusion
Adele CARLIER-GONOD
Other
Evaluation of Knowledge and Practices About Contraception, Sexuality and Transmission Among Adolescents With Sickle Cell Disease.
Acronym: SEXODREP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04691323
Anemia, Anemia, Hemolytic
Chicago, Illinois, United States
View Trial DetailsNCT04688411
Anemia, Anemia, Hemolytic
Chicago, Illinois, United States
View Trial DetailsNCT05405114
Anemia, Anemia, Hemolytic
Mobile, Alabama, United States
View Trial DetailsNCT07721155
Anemia, Anemia, Hemolytic
Amsterdam, Netherlands
View Trial Details